Is neoadjuvant chemotherapy combined with immunotherapy really better than neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma?

This study comparing neoadjuvant chemotherapy combined with immunotherapy (NACI) versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma provides substantial insights into the evolving landscape of cancer treatment modalities.

Source: The Journal of Thoracic and Cardiovascular Surgery - March 27, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Kexun Li, Jiapeng Yang, Ynchao Huang Tags: Letter to the Editor Source Type: research